Minerva Surgical, Inc. Common Stock
UTRS
UTRS was delisted on the 28th of December, 2023.
20 hedge funds and large institutions have $84.7M invested in Minerva Surgical, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 7 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
18% less capital invested
Capital invested by funds: $103M → $84.7M (-$18.3M)
20% less funds holding
Funds holding: 25 → 20 (-5)
38% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 8
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIC
AWM Investment Company
New York
|
+$3.07M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$757K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$172K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$127K |
| 5 |
Morgan Stanley
New York
|
+$50.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LM
Luminus Management
Houston,
Texas
|
-$3.28M |
| 2 |
CCM
CAAS Capital Management
New York
|
-$570K |
| 3 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
-$386K |
| 4 |
Two Sigma Investments
New York
|
-$227K |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$216K |
UTRS Hedge Fund Activity: Q1 2022 in Review
20 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Minerva Surgical, Inc. Common Stock (UTRS) for Q1 2022, worth a combined $84.7M — down 18% from $103M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of UTRS and 2 opened new positions — a net loss of 5 holders — while 8 trimmed existing stakes and 5 added.
The largest buyer was AWM Investment Company, adding an estimated $3.07M. The largest seller was Luminus Management, cutting an estimated $3.28M.
- 20 institutional investors held Minerva Surgical, Inc. Common Stock (UTRS) as of Q1 2022, down from 25 in Q4 2021.
- Funds reported $84.7M of Minerva Surgical, Inc. Common Stock stock for Q1 2022, down 18% quarter-over-quarter.
- 2 funds opened new Minerva Surgical, Inc. Common Stock positions in Q1 2022 and 7 closed out, a net change of -5 holders.
- The largest Minerva Surgical, Inc. Common Stock buyer in Q1 2022 was AWM Investment Company, an estimated $3.07M added.
- The largest Minerva Surgical, Inc. Common Stock seller in Q1 2022 was Luminus Management, an estimated $3.28M sold.
Based on aggregated 13F filings for Q1 2022.